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Abstract
The ability of many viruses to manipulate the host antiviral immune response often results in complex host-pathogen
interactions. In order to study the interaction of dengue virus (DENV) with the Aedes aegypti immune response, we have
characterized the DENV infection-responsive transcriptome of the immune-competent A. aegypti cell line Aag2. As in
mosquitoes, DENV infection transcriptionally activated the cell line Toll pathway and a variety of cellular physiological
systems. Most notably, however, DENV infection down-regulated the expression levels of numerous immune signaling
molecules and antimicrobial peptides (AMPs). Functional assays showed that transcriptional induction of AMPs from the Toll
and IMD pathways in response to bacterial challenge is impaired in DENV-infected cells. In addition, Escherichia coli, a Gram-
negative bacteria species, grew better when co-cultured with DENV-infected cells than with uninfected cells, suggesting a
decreased production of AMPs from the IMD pathway in virus-infected cells. Pre-stimulation of the cell line with Gram-
positive bacteria prior to DENV infection had no effect on DENV titers, while pre-stimulation with Gram-negative bacteria
resulted in an increase in DENV titers. These results indicate that DENV is capable of actively suppressing immune responses
in the cells it infects, a phenomenon that may have important consequences for virus transmission and insect physiology.
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Introduction
The incidence and geographic range of dengue and dengue
hemorrhagic fever has increased dramatically in recent decades.
With 2.5 billion people now living in areas at risk for epidemic
transmission, dengue has become the most important mosquito-
borne viral disease affecting humans [1]. Dengue virus (DENV) is a
positive-strand RNA virus of the family Flaviviridae, genus Flavivirus.
It exists as four closely related but antigenically distinct serotypes
(DENV-1, -2, -3, and -4), all of which have Aedes aegypti mosquitoes
as their primary vector, with A. albopictus as a secondary vector.
Mosquitoes, like all insects, are exposed to a variety of microbes
in their natural habitats, and possess an innate immune system
that is capable of mounting a potent response against microbial
challenge. The insect innate immune response is largely regulated
by three main immune signaling pathways: the Toll, immune
deficiency (IMD) and Janus kinase signal transducer and activator
of transcription (JAK-STAT) pathways. The Toll pathway is
involved in defense against fungi, Gram-positive bacteria, and
viruses [2–4], and has been found to be specifically involved in the
A. aegypti anti-DENV response [5]. The IMD pathway has a major
role in the production of antimicrobial peptides (AMPs) that
control Gram-negative bacterial infections [6], and has more
recently been shown to control Sindbis virus (SINV) infection in
Drosophila melanogaster [7]. Likewise, the JAK-STAT pathway has
been implicated in antiviral defense in insects [8], including
defense against DENV in A. aegypti [9].
Despite the well-documented involvement of the Toll, IMD,
and JAK-STAT pathways in insect antiviral defense, very little is
known about how these pathways are activated by viruses at the
molecular level. For example, viral pathogen-associated molecular
patterns (PAMPs) and their associated insect pattern recognition
receptors (PRRs) have not yet been identified, and only a few
putative antiviral effector molecules have been identified [9,10].
The host antiviral response is often countered by the ability of
viruses to suppress or evade host immune responses. For example,
several DENV non-structural proteins are known to play roles in
the suppression of the mammalian interferon signaling pathway
[11–13]. However, although this suppression and the mechanisms
by which it occurs are well-characterized in the vertebrate system,
very little is known about whether similar processes are at work in
the mosquito vector.
In the mosquito, a detailed molecular characterization of the
innate response to virus infection is complicated by the presence of
many different tissues and body compartments. For this reason, we
decided to characterize the mosquito anti-DENV response using
the immune-competent Aag2 Aedes aegypti cell line [14,15]. We
reasoned that the cell line would be a more homogenous and
sensitive system, thus allowing us to detect more subtle changes in
gene expression in response to viral infection.
Our microarray analysis of the Aag2 DENV-responsive
transcriptome indicated that DENV regulates a large number of
genes from diverse classes in the Aag2 cell line, and, most
strikingly, down-regulates a number of immune effectors and
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inhibiting immune pathways in these cells. Functional assays
indicated that DENV-infected cells are less capable of mounting
an immune response against secondary bacterial challenge, and
challenge with immune-response elicitors prior to DENV infection
did not result in reduced virus infection, suggesting that the virus is
actively suppressing immune pathways rather than failing to
trigger them.
Results
a) Cell line transcriptome responses to DENV
In accordance with previous studies [16], we found the Aag2
cell line readily permissible to infection with DENV (Figure 1E). In
order to assess the global transcriptional response pattern of the
Aag2 cell line to DENV infection, we employed a whole genome
oligonucleotide microarray to compare transcript abundance in
non-challenged cells to that in cells that had been challenged with
either live virus (DENV) or heat-inactivated virus (HIA DENV) at
an MOI of 1, at 48h post-infection (pi). This time point is relatively
early in DENV infection, and was chosen to allow for sampling of
the transcriptome while the virus was actively replicating: the
length of one DENV replication cycle is estimated to be ,30h
[17], and a growth curve of DENV infection in Aag2 cells showed
that DENV titers were increasing steadily at 48hpi, peaking only
around 5 days pi (data not shown).
DENV infection significantly regulated 587 genes in the cell line
(391 induced and 196 repressed), while HIA DENV exposure
resulted in the regulation of 302 genes (170 up-regulated and 132
down-regulated) (Figure 1A), suggesting that virus replication
accounts for a large proportion of the cellular response to DENV.
A total of 36 genes were up-regulated and 74 were down-regulated
by both challenges (Figure 1A), suggesting that these genes may be
regulated in response to the recognition of viral PAMPs. Among
the genes that were up-regulated by both challenges were several
hypothetical proteins containing transmembrane domains (includ-
ing one containing leucine-rich repeats [LRRs]), and a tyrosine-
kinase related protein, which could be involved in virus
recognition or downstream signaling processes. The fact that we
did not find oppositely regulated genes under the two experimental
conditions suggests that live and HIA DENV may trigger very
similar cellular pathways (Figure 1A).
Live DENV infection significantly regulated genes that are
involved in diverse cellular physiological systems (Figure 1B).
Some 37 genes with putative immune functions were significantly
regulated by DENV (Table S1). Of these, 16 were up-regulated,
including the Toll pathway components Toll and Cactus, PRRs (a
peptidoglycan recognition protein [PGRP] and a galactoside-
binding lectin [GALE]), and signal modulators (two C-type lectins
[CTLs] and a scavenger receptor). Interestingly, a putative heat-
shock protein, HSP70, which has been implicated as part of the
DENV receptor complex in human cells [18], was also among the
up-regulated immune-related genes. In addition, 29 of the 41
significantly regulated genes with putative metabolic functions
were up-regulated, perhaps indicating a shift in the metabolic state
of the cell to support virus replication [19]. For example, several
glucosyl/glucuronosyl transferases (enzymes involved in protein
glycosylation) were induced, as was as Sec24B, a component of the
COPII protein complex required for vesicle budding from the ER.
This could indicate increased production and trafficking of viral
proteins. There was also an up-regulation of enzymes involved in
amino acid biosynthesis and fatty acid biosynthesis and elongation,
perhaps indicating the increased use of host pathways for the
synthesis of viral components. Of the 26 significantly regulated
genes with putative transport functions, 21 were up-regulated,
possibly as a result of increased vesicle transport or the use of
transmembrane transporters as virus receptors. DENV also
induced the transcription of a DEAD box-ATP-dependent RNA
helicase and a DEAD box polypeptide-encoding gene; this finding
is noteworthy because it was recently shown that Drosophila Dicer-
2, a DExD/H-box helicase, is capable of sensing viral dsRNA and
inducing the production of a putative antiviral effector molecule
[10].
Six ubiquitin-proteasome pathway-related genes were induced
in live DENV-infected cells. Transcriptional activation of this
pathway has also been reported in DENV-infected mammalian
cells [20,21], and treatment with proteasome inhibitors has been
reported to impair DENV replication in liver-derived HepG2 cells
[20]. This suggests that the virus may use components of this
pathway for replication in both invertebrate and vertebrate
systems.
Unexpectedly, HIA DENV induced twice as many immune-
related genes as did live DENV (33 of 170 up-regulated genes, or
19.4% for HIA DENV, as compared to 16 of 391, or 4.1% for
DENV) (Figure 1B, Table S1). Transcriptional activation of Toll
pathway components also occurred in HIA DENV-infected cells,
with up-regulation of two Tolls, MyD88, and Rel1. A broader
range of immune-related genes was up-regulated in HIA DENV-
infected cells, including PRRs (a Gram-negative bacteria-binding
protein [GNBP] and three fibrinogen and fibronectin related
proteins [FREPs]), signal modulators (several CTLs, a clip-domain
serine protease [CLIP] and a serine protease inhibitor [serpin]),
and several oxidative defense enzymes. Other up-regulated
immune genes included a transcript from the Down syndrome
cell adhesion molecule (DSCAM) gene, which in Anopheles gambiae
generates a wide range of PRRs that are involved in the defense
against bacteria and Plasmodium [22], and two proteins with
suppressor of cytokine signaling (SOCS) domains. Members of the
SOCS gene family are induced upon JAK-STAT pathway
activation and function in a negative feedback loop to inhibit
the catalytic activity of JAK [23].
Cell line challenges led to the regulation of a unique set of genes
when compared to DENV infection of the mosquito carcass [5]
(Figure 1A). The transcript abundance of certain genes in the
mosquito carcass could reflect an averaging of gene expression
levels across a variety of tissues and organs and therefore result in a
lack of difference between the compared samples, whereas the cell
line is likely a more homogenous, simpler and more sensitive
system.
The Toll, JAK-STAT, and IMD pathways are negatively
regulated by Cactus, PIAS, and Caspar, respectively. Our group
has previously characterized the transcriptomes of immune
pathway-activated A. aegypti through RNAi-mediated depletion of
these negative regulators [5,9]. A comparison of the DENV-
infected cell transcriptome with those of Cactus-, PIAS-, and
Caspar-silenced mosquitoes revealed the greatest overlap with the
Cactus-silenced (or Rel1-activated) transcriptome (22% of the
DENV-infected cell transcriptome), followed by the PIAS (3.7%)
and Caspar (1.5%) silencing-regulated transcriptomes (Figure 1C).
Interestingly, four AMPs (three cecropins and one defensin) were
down-regulated in the virus-challenged cell line as well as in JAK-
STAT pathway activated (by PIAS silencing) mosquitoes,
suggesting that JAK-STAT pathway activation during DENV
infection of the cell line may be responsible for the regulation of
these immune effectors. These findings are in agreement with our
previous observation that the Toll and JAK-STAT pathways
regulate anti-DENV defense in adult mosquitoes, but the IMD
pathway does not [5,9].
Dengue Immune Suppression
PLoS ONE | www.plosone.org 2 May 2010 | Volume 5 | Issue 5 | e10678Figure 1. Transcriptional regulation of genes in the Aag2 cell line in response to live dengue virus (DENV) and heat-inactivated
dengue virus (HIA DENV) infection. A. Venn diagram showing the numbers of unique and commonly regulated genes in DENV- and HIA DENV-
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down-regulated a large number of immune-related genes (21 of
196, or 10.7% of all down-regulated genes) in the cell line. Among
the repressed immune genes were PRRs (a PGRP, a GNBP, two
FREPs, and a thio-ester containing protein [TEP]), signal
modulators (several serine proteases and CTLs) and AMPs (six
cecropins and two defensins) (Table S1).
In live mosquitoes, RNAi-mediated depletion of the Toll
pathway negative regulator Cactus results in the induction of
numerous immunity-related genes [5]. To further explore the
repression of immune genes observed during DENV infection of
the cell line, we performed a cluster analysis of significantly
regulated genes in challenged cells and in Cactus-silenced (or
Rel1-activated) mosquitoes. This analysis revealed that numerous
genes were oppositely regulated in DENV-infected cells and
Cactus-silenced mosquitoes (expression clusters III and V,
Figure 1D). Of particular interest was expression cluster V, which
was enriched in immune genes that were repressed by DENV
infection in the cell line but induced by Cactus silencing in
mosquitoes.
The simultaneous up- and down-regulation of immune-related
genes in the cell line by DENV is intriguing and suggests that
DENV selectively evades or suppresses certain aspects of the
mosquito’s immune response. Analysis of the infection-responsive
genes did not allow us to narrow this transcription signature down
to a specific pathway or function, since many of the repressed
genes (such as AMPs) can be regulated by one or more pathways.
b) DENV-infected cells are compromised in mounting an
immune response to secondary bacterial challenge
Challenge of mosquito cells with bacteria typically results in a
robust induction of AMP expression in the cells. We hypothesized
that if DENV suppresses immune signal transduction pathways
and thereby transcription of effectors in the cell line, DENV-
infected cells may be less able to mount an immune response to a
secondary challenge with bacteria. Therefore, we infected cells
with DENV at an MOI of 1 for 48 h, and then challenged them
with 10 MOI of heat-killed E. coli (a Gram-negative bacteria
species, known to activate the IMD pathway) or S. aureus (Gram-
positive, known to activate the Toll pathway). Cell lysates were
harvested at 2, 6, and 18 h after bacterial challenge, and
expression levels of the AMP genes cecropin and defensin were
measured by semi-quantitative PCR (Figure 2).
Secondary challenge with either bacterial species resulted in the
rapid and robust induction of cecropin expression when compared
to the unchallenged controls in the case of both DENV- and
control mock-infected cells at all time points (p,0.01) (Figure 2).
However, cecropin induction levels were lower in DENV-infected
cells: At 2 h post-E. coli challenge, cecropin levels in mock-infected
cells were .2-fold higher than in DENV-infected cells (p,0.05),
and the same was true at 6 h post-S.aureus challenge (p,0.05)
(Figure 2A). The difference in the kinetics of cecropin induction by
the two bacterial species may potentially be explained by inherent
differences in how Gram-negative and Gram-positive bacteria
trigger an immune response.
As was the case for cecropin expression, significantly lower
levels of defensin were produced by DENV-infected cells than by
mock-infected cells at 2 h post-E. coli stimulation (p,0.01). In fact,
while E. coli-challenged mock-infected cells induced significantly
higher levels of defensin than did unchallenged cells (p,0.05),
defensin levels for E. coli-challenged DENV-infected cells were not
significantly different from those of unchallenged cells (Figure 2B).
In addition, DENV-infected cells also produced significantly lower
defensin levels at 18 hours post-challenge with both E. coli
(p,0.01) and S. aureus (p,0.05) (Figure 2B).
At 6 h after E. coli and S. aureus challenge, the level of defensin
expression in bacteria-challenged cells was not significantly
different from that in non-challenged cells (Figure 2B). This result
reflects the fact that the unchallenged cells displayed slightly higher
levels of defensin at this time point, and may also reflect the
natural variation of baseline defensin levels in this cell line over
time.
These data suggest that DENV is capable of repressing the
induction of AMPs that are regulated by both the Toll and IMD
pathways.
c) DENV-infected cells are compromised in inhibiting the
growth of bacteria in co-culture
A variety of insect cells display antibacterial activities and can
therefore inhibit the growth of bacteria in co-culture, presumably
through phagocytosis and the secretion of AMPs into the cell
culture medium [24]. Since the data presented above suggested
that DENV is able to repress AMP production in response to
bacterial challenge, we hypothesized that prior infection with
DENV would result in a reduced antibacterial activity. In order to
test this hypothesis, cells were infected with DENV or mock-
infected for 48 h, and then challenged with live bacteria in 10-fold
dilutions ranging from 1.4610
7 to 1.4 bacterial cells per well. The
OD595 was determined at 12 h after bacterial challenge as a
measure of bacterial growth.
As expected, E.coli co-cultured with Aag2 cells grew to a lower
OD595 than E. coli grown alone (p,0.05 at dilutions 3 to 6,
dilution 8) (Figure 3A). In addition, E. coli co-cultured with DENV-
infected Aag2 cells grew to a higher OD595 than E. coli co-
cultured with uninfected cells (p,0.05 at dilutions 4 to 7)
(Figure 3A), in agreement with our hypothesis that DENV
infection compromises the ability of the cells to mount an immune
response against bacteria. However, co-culture with uninfected or
DENV-infected cells did not affect the OD595 of the Gram-
positive bacteria S. aureus and M. luteus (Figure 3B and C),
suggesting that these species are more resistant to the AMPs
produced by the cells. In a separate experiment, we incubated
DENV and bacteria together for 12 h and confirmed that the virus
does not have a direct effect on OD595 (data not shown).
infected cells and DENV-infected mosquito carcass. Arrows indicate the direction of gene regulation. B. Functional classification of significantly
regulated genes in DENV and HIA DENV infection; arrows indicate the direction of gene regulation. Functional group abbreviations are as follows:
UNK, unknown functions; DIV, diverse functions; MET, metabolism; RTT, replication, transcription, and translation; TRP, transport; CS, cytoskeletal and
structural; PROT, proteolysis; DIG, blood and sugar food digestive; CSR, chemosensory reception; RSM, redox, stress and mitochondrion; IMM,
immunity. C. Comparative analysis of the DENV infection-responsive cell line transcriptome and the Toll-, IMD-, and JAK-STAT pathway-regulated
mosquito transcriptomes. Venn diagrams show the numbers of unique and commonly regulated genes in DENV-infected Aag2 cells and Cactus-,
Caspar-, and PIAS-silenced A. aegypti mosquitoes. Arrows indicate the direction of gene regulation. D. Cluster analysis of 238 genes that were
regulated in at least two of three treatments: DENV infection in the cell line, HIA DENV infection in the cell line, Cactus silencing in A. aegypti
mosquitoes. All genes presented in this cluster analysis are listed in Table S6. E. Detection of DENV in Aag2 cells by indirect immunofluorescence
assay using mouse hyperimmune ascitic fluid specific for DENV2 (CDC) and an AlexaFluor488-conjugated goat anti-mouse secondary antibody. Blue:
DAPI, Green: FITC.
doi:10.1371/journal.pone.0010678.g001
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to suppress DENV infection
The lack of immune gene up-regulation by DENV infection
that we observed could be due to the virus evading or failing to
trigger an immune response, or alternatively to an active immune
suppression mechanism. Therefore, we wanted to determine
whether pre-immune activation by challenging with Gram-positive
or Gram-negative bacteria prior to virus infection would affect
DENV titers derived from the cells. For this purpose, cells were
stimulated with 10 MOI of heat-killed E.coli or S. aureus for 24 h
prior to infection with DENV at an MOI of 0.01, and DENV
titers were determined every 24 h thereafter.
DENV titers in cells pre-challenged with S. aureus closely
paralleled those in control cells (pre-treated with PBS) except at 2
days post-DENV infection, when S. aureus-treated cells produced
significantly higher DENV titers than control cells (p,0.01)
(Figure 4). This suggests that DENV is actively suppressing at
least part of the immune response that is triggered by exposure to
S. aureus, or alternatively that the virus is not affected by this
response. Another explanation could be that S. aureus triggers
other non-immune cellular pathways that favorably affect virus
growth.
Unexpectedly, pre-challenge of the cells with E. coli resulted in
higher DENV titers at all time points post-virus infection,
significantly at 2 and 4 days post-DENV infection as compared
to the PBS-treated controls (p,0.01 and p,0.05 respectively)
(Figure 4). A plausible explanation for these results is that the E. coli
challenge-elicited immune response exhausted the cell’s capacity
to produce anti-dengue effectors. This situation would imply
that in a normal infection scenario, the IMD pathway also
participates in anti-DENV defense, together with the Toll
pathway.
Discussion
In order to examine the response of A. aegypti to DENV infection
in a more homogenous and sensitive system, we have character-
ized the DENV infection-responsive transcriptome of the immune-
competent A. aegypti cell line Aag2. The cellular response to DENV
infection involved a variety of physiological systems and functional
gene classes, indicating that virus replication has a substantial
effect on cell physiology.
DENV infection of the cell line and the mosquito carcass [5]
resulted in the regulation of unique subsets of genes. These
differences could be due to several factors: First, different time
points were sampled in the two data sets: The cell line
transcriptome was determined at 48 h post-infection, whereas
the mosquito transcriptome was characterized at 10 days post-
infection, which is relatively late in the infection process. It would
be interesting to carry out a microarray analysis of DENV
infection in the mosquito at the very early stages of infection
(eg,24 h post-infectious bloodmeal) and compare the results to
our cell line data. Second, as mentioned above, the mosquito
carcass comprises many different tissue types and organs; thus, the
transcriptome may reflect an averaging across these heterogene-
ities as well as the sum total of the transcript abundance in the
different tissues and cell types. Despite these differences, however,
viral challenge of the cell line also transcriptionally activated
several Toll pathway components, further strengthening the
evidence for the role of this pathway in antiviral defense.
A striking difference between DENV infection in the cell line
and in the mosquito carcass was the relative lack of immune gene
activation in the cell line. Immune genes made up only 4.1% of
up-regulated genes in the cell line but constituted 22.5% of up-
regulated genes in the mosquito carcass. Further, DENV infection
Figure 2. DENV-infected cells are less able to produce antimicrobial peptides in response to secondary bacterial challenge. Aag2
cells were DENV- or mock-infected, then challenged or mock-challenged with heat-killed E. coli or S. aureus. The bar charts show the -fold change in
(A) cecropin and (B) defensin gene expression levels relative to levels at the 0-h time point for each sample, as measured by semi-quantitative PCR.
Error bars indicate the standard error of the mean; ND, non-detectable.
doi:10.1371/journal.pone.0010678.g002
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cell line. This suggests that the immune modulation observed in
DENV-infected cells is an active suppression mechanism that may
require a replicating virus or, alternatively, could be triggered by
the interaction with, or internalization of, the virus in absence of
replication. Immune genes induced by exposure to HIA DENV
comprised 19.4% of up-regulated genes, a value comparable to
that for the mosquito carcass, and a broad down-regulation of
immune genes was not observed.
We have further demonstrated that DENV-infected cells are less
able to produce transcripts of the AMPs cecropin and defensin in
response to challenge with Gram-positive and Gram–negative
bacteria, suggesting that DENV is repressing the immune
pathways that mediate these responses. In addition, E. coli co-
cultured with DENV-infected cells was able to grow to a higher
OD than bacteria cultured with uninfected cells, providing further
evidence that DENV suppresses an antibacterial immune
response.
Since cellular metabolism is presumably altered by DENV
infection, we cannot rule out the possibility that the increased
proliferation of E. coli in co-culture with DENV-infected cells
could be attributed to changes in levels of metabolites released
from virus-infected cells, instead of to decreased AMP levels. For
example, several enzymes involved in fatty acid and amino acid
biosynthesis were induced in DENV-infected cells. However, given
the nutrient-rich nature of cell culture media, we find it unlikely
that changes in metabolite levels released from the cells would
have a marked effect on bacterial growth. Taking into account the
finding that DENV-infected cells are impaired in their ability to
produce AMPs in response to secondary bacterial challenge, it is
likely that the increased bacterial proliferation is at least partly due
to decreased AMP levels.
Further, while it cannot be ruled out that the virus is causing an
overall down-regulation of host gene expression instead of
specifically targeting immune signaling pathways, our microarray
data do not suggest this: DENV induced twice the number of
genes it repressed, and immune-related genes were the largest
specific class of down-regulated genes (excluding those with
unknown and diverse functions).
Many viruses suppress or evade immune signaling pathways,
and DENV is no exception. The DENV NS4B protein
Figure 3. DENV-infected cells are less able to inhibit the
growth of Gram-negative bacteria in co-culture. Eight 10-fold
dilutions of Gram-positive or Gram-negative bacteria were inoculated
into the cell culture medium in 96-well plates containing DENV- or
mock-infected Aag2 cells, or cell culture medium alone. The graphs
show OD595 as a measure of bacterial growth after a 12-h incubation
at 28uC for (A) E. coli, (B) S. aureus, and (C) M. luteus. * represents
p,0.05 in a Student’s t-test comparing OD595 of bacteria incubated
with DENV- and mock-infected cells. Error bars indicate the standard
error of the mean; note that in many cases the error bars are obscured
by the data point.
doi:10.1371/journal.pone.0010678.g003
Figure 4. Effect of pre-immune stimulation on DENV titers in
the cell line. Aag2 cells were pre-immune stimulated by the addition
of heat-killed E. coli and S. aureus 24 h prior to DENV infection. The
graph shows log10 DENV titers over 7 days as determined by plaque
assay for cells pre-stimulated with heat-killed E. coli or S. aureus,o r
mock-stimulated with PBS. { represents p,0.05 in a Student’s t-test
comparing DENV titers in S. aureus- and mock-stimulated cells; *
represents p,0.05 in a Student’s t-test comparing DENV titers in E. coli-
and mock-stimulated cells. Error bars indicate the standard error of the
mean.
doi:10.1371/journal.pone.0010678.g004
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phosphorylation and activation, preventing STAT dimers from
translocating to the nucleus [11,12], and DENV NS5 has more
recently been shown to bind STAT2 and target it for proteasomal
degradation [13]. The related flavivirus Japanese encephalitis virus
(JEV) inhibits STAT phosphorylation in both vertebrate [25,26]
and mosquito (C6/36) cells [27]. Semliki Forest virus (SFV) has
been found to reduce Toll, IMD and JAK-STAT signaling in
mosquito cells [22], and Sindbis virus (SINV) infection of A. aegypti
mosquitoes has been suggested to inhibit the Toll pathway after an
initial activation stage [28]. Insect viruses are also capable of
immune pathway suppression: For example, the Microplitis demolitor
bracovirus inhibits Toll and IMD signaling as well as antimicrobial
melanization reactions [29–31].
In our study, immune challenge with Gram-positive bacteria
(which have been shown to activate the Toll pathway) did not
affect DENV titers, in agreement with what has been observed for
SINV [22], and suggesting that DENV may actively suppress the
Toll pathway rather than evade it. Prior immune challenge with
Gram-negative bacteria, which are known to activate the IMD
pathway, unexpectedly resulted in higher DENV titers. We
speculate that robust stimulation of this pathway by E. coli
challenge may have exhausted the cell’s capacity to produce IMD
pathway-regulated effectors, thus allowing DENV to replicate
more freely. A similar effect was seen in A. aegypti mosquitoes, in
which IMD pathway activation through Caspar silencing resulted
in increased midgut DENV titers, although this increase was not
statistically significant [5]. This interpretation would suggest that
the IMD pathway plays a role in keeping DENV replication in
check in a normal infection scenario. While up-regulation of IMD
pathway components in response to DENV infection was not
observed in the cell line or in the mosquito [5], this lack of
regulation may be attributable to a balance between IMD
pathway activation and DENV suppression of this pathway. It
would be interesting to pursue the role of the IMD pathway in
anti-DENV response, especially in light of two recent studies that
have implicated this pathway in the antiviral response against
SINV and cricket paralysis virus (CrPV) in D. melanogaster infection
models [7,32].
Our group has recently shown that there is also a down-
regulation of several AMPs at early time points in DENV infection
in live mosquitoes [33], suggesting that DENV may suppress
immune responses at early infection stages before activating them
at later time points, and indicating that our cell line data is
applicable to a real-life infection scenario. An immune-suppressive
effect of DENV in the mosquito at the early stages of infection
could aid in establishing viral infection in the midgut. Since
productively infected mosquitoes are capable of transmitting
DENV for life, and also take multiple bloodmeals over a single
gonatrophic cycle [34], an increased ability of DENV to overcome
bottlenecks at the midgut infection stage could have implications
for virus transmission. It would be interesting to determine
whether DENV strains that differ in their ability to establish
productive infections in mosquitoes also differ in their immune-
suppressive activity.
In addition, a reduction in AMP expression in response to
DENV infection may have physiological repercussions for the
mosquito in nature. Mosquitoes are constantly exposed to bacteria
and fungi in their environments, and rely on their innate immune
system to keep bacterial infection in check. Suppression of immune
pathways by arbovirus infection could lead to a proliferation of
pathogenic or opportunistic bacteria, especially if viral infection
brings about tissue damage that could increase the mosquito’s
susceptibility to septic infection.
There is growing interest in the similarities between DENV
infection in mosquito and mammalian systems. A recent study
found that numerous host factors required for DENV replication
are conserved between invertebrate and vertebrate hosts [35]. Our
microarray gene expression data revealed some overlaps between
the mosquito and mammalian cell DENV-regulated transcrip-
tomes, including up-regulation of ubiquitin-proteasome pathway
components [20,21], as well as cytoskeletal- and transport-related
genes [20]. These overlaps suggest that drug targets developed for
use in humans may also be useful for interventions in the vector.
In summary, the data presented here indicate that DENV is
capable of inhibiting immune pathway activation in mosquito cell
lines. Because of its small genome size and the high degree of
conservation between the invertebrate and vertebrate innate
immune systems, it is intriguing to hypothesize that DENV has
evolved similar methods of immune suppression in both
mosquitoes and humans. Our future studies will focus on the
mechanisms by which DENV causes immune suppression in the
invertebrate, as well as the effect that this suppression has on virus
transmission.
Materials and Methods
a) Cell culture and DENV infection
Aedes aegypti Aag2 cells [14,15] were maintained at 28uCi n
Schneider’s Drosophila media with L-glutamine supplemented with
10% FBS and 1% penicillin/streptomycin, and were passaged at a
1:10 dilution every 4–5 days. At 70–80% confluency, the cells
reached a density of ,1.8610
5 cells/cm
2.
For infection, Aag2 cells were seeded in 6-, 24-, or 96-well plates
to a confluency of 80%. DENV2 New Guinea C (NGC) diluted to
the desired multiplicity of infection (MOI) in infection medium
(Schneider’s Drosophila medium with L-glutamine, supplemented
with 2% FBS, 1% penicillin/streptomycin, and 1% non-essential
amino acids) was then added to the cells. After rocking at room
temperature for 1 h, the inoculum was aspirated, and the
appropriate volume of infection medium was added to top up
each well of the plate. Plates were incubated at 28uC for the
duration of the experiment.
b) Indirect immunofluorescence assay
To confirm infection, Aag2 cells infected with DENV2 an
MOI of 1.0 were fixed in acetone on a microscope slide for
10 min at 220uC. After blocking for 1 h at room temperature in
10% goat serum, 0.1% TritonX-100 and 0.2% BSA in PBS, the
slide was incubated with DENV2 mouse hyperimmune ascitic
fluid (MHIAF, specific for DENV-2, CDC), followed by Alexa-
Fluor 488-conjugated goat anti-mouse IgG for 1 hour each at
room temperature. Slides were mounted with ProLong Gold anti-
fade reagent with DAPI, and visualized under a fluorescent
microscope.
c) Microarray gene expression analysis
Aag2 cells were seeded to a confluency of 80% in 6-well plates
and infected in triplicate with the following:
a) DENV at an MOI of 1.
b) Heat-inactivated DENV (HIA DENV) at an MOI of 1.
DENV was heat-inactivated by heating at 70uC for 1 h.
c) PBS (mock-infected control).
After incubation at 28uC for 48 h, infected and control cells
were lysed by the addition of 600 ml of Buffer RLT (Qiagen) and
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then extracted with the Qiagen RNeasy Mini Kit.
Two micrograms of total RNA were used for probe synthesis of
cy3- and cy5-labeled cRNA, and hybridizations were carried out
on an Agilent-based microarray platform. Hybridization intensities
were determined with an Axon GenePix 4200AL scanner, and
images were analyzed with Gene Pix software.
Expression data were processed and analyzed as previously
described [5,9]; in brief, background-subtracted median fluorescent
vales were normalized with the LOWESS normalization method,
andCy5/Cy3 ratiosfrom replicate assayswere subjected to t-testsat
a significance level of p,0.05 using TIGR MIDAS and MeV
software. Expression data from replicate assays were averaged with
the GEPAS microarray preprocessing software and logarithm (base
2)-transformed. Self–self-hybridizations have been used to deter-
mine the cutoff value for the significance of gene regulation on these
types of microarrays to 0.78 in log2 scale, which corresponds to
1.71-fold regulation [36]. For genes with p,0.05, the average ratio
was used as the final -fold change; for genes with p.0.05, the
inconsistent replicates (with distance to the median of replicate
ratios .0.8) were removed, and only the values from genes with at
least two replicates in the same direction of regulation were further
averaged. Numeric microarray gene expression data are presented
in Table S2. We have made all microarray data MIAME compliant
and available through the public databases of NCBI-GEO
(accession numbers: GSM472993, GSM472992, GSM472991,
GSM472990, GSM472989, GSM472988).
d) DENV-bacteria co-infections
Aag2 cells seeded in 24-well plates were infected or mock-
infected with DENV for 48 h at an MOI of 1 [15]. Heat-killed
Escherichia coli or Staphylococcus aureus diluted in PBS was then added
to the cell culture medium to an MOI of 10 (bacteria were heat-
killed by heating at 70uC for 30 min). As a mock-challenged
control, an equivalent volume of PBS was added to the cells. All
conditions were performed in triplicate.
At 0, 2, 6 and 18 h after bacterial challenge, the media were
aspirated, and the cells were lysed by the addition of 350 mlo f
Buffer RLT. Lysates were homogenized for 30 s with a rotor-
stator homogenizer, and RNA was then extracted with the Qiagen
RNeasy Mini Kit.
e) Semi-quantitative PCR
RNA samples were DNAse-treated using the Ambion Turbo
DNAse kit, and 1 mg of total RNA was then reverse-transcribed
with Superscript III (Invitrogen) using oligo(dT) primers. Separate
PCRs were carried out for each gene being analyzed, and products
were separated by gel electrophoresis and visualized on a Fuji
image documenter system. Signal intensities from gel bands were
quantified with the ImageGauge software (Fuji), and each sample
was normalized to transcript levels of the A. aegypti ribosomal S7
gene. The primer sequences used were:
Cecropin G (AAEL015515-RA):
F: 59-TCACAAAGTTATTTCTCCTGATCG-39
R: 59-GCTTTAGCCCCAGCTACAAC-39
Defensin C (AAEL003832-RA):
F: 59-TTGTTTGCTTCGTTGCTCTTT-39
R: 59-ATCTCCTACACCGAACCCACT-39
S7 (AAEL009496-RA):
F: 59-GGGACAAATCGGCCAGGCTATC-39
R: 59-TCGTGGACGCTTCTGCTTGTTG-39
Numeric data for the semi-quantitative PCR assays are
presented in Table S3.
f) Bacterial growth inhibition assays
Bacterial growth inhibition assays were carried out on the basis
of the protocol described in [24]. Aag2 cells seeded in 96-well
plates were infected or mock-infected with DENV at an MOI of 1,
and 60 ml of antibiotic-free medium was added to each well after
aspiration of the inoculums [15]. Wells containing 60 mlo f
medium alone were also included as a control. The cells were
incubated at 28uC for 48 h to allow for the accumulation of
antimicrobial effectors in the cell culture supernatant. Overnight
cultures of E. coli, S. aureus, and Micrococcus luteus were washed in
PBS and diluted to ,1.0 OD600, and eight serial 10-fold dilutions
of bacteria were prepared from the original dilution. Samples
(140 ml) of each bacterial dilution were added to wells containing
infected cells, mock-infected cells, or medium alone in the 96-well
plates. Plates were incubated for 12 h at 28uC, and the OD595
was measured using a microplate reader (Molecular Devices).
Each dilution and sample was replicated four times. Numeric
OD595 values are presented in Table S4.
g) Plaque assays
Aag2 cells seeded in 96-well plates were pre-challenged with 10
MOI of heat-killed E. coli and S. aureus or mock-challenged with
PBS for 24 h prior to infection with DENV at an MOI of 0.01
[15]. Cell culture supernatants (200 ml) were harvested every 24 h
up to 7 days and replaced with 200 ml of fresh infection medium.
DENV titers in harvested supernatants were determined by
plaque assay. Samples were serially diluted and inoculated into
C6/36 cells in 24-well plates. After a 5-day incubation period at
32uC and 5% CO2, plaque forming units (PFUs) were visualized
by immunoperoxidase staining using mouse hyperimmune ascitic
fluid (MHIAF, specific for DENV2, CDC) as the primary antibody
and a goat anti-mouse horseradish peroxidase conjugate as the
secondary antibody [5,9]. Numeric DENV titers from the plaque
assays are presented in Table S5.
Supporting Information
Table S1 Significantly regulated putative immune- and infec-
tion-related genes in DENV- and HIA DENV-infected Aag2 cells,
and their overlap with those in Cactus-silenced A. aegypti
mosquitoes. Aag2 cells were harvested for microarray analysis at
48 h post-challenge with 1 MOI of DENV or HIA DENV.
Mosquitoes were injected with dsRNA to Cactus at 2-4 days post-
emergence, and samples were collected for microarray analysis at
4 days after injection.
Found at: doi:10.1371/journal.pone.0010678.s001 (0.08 MB
DOC)
Table S2 Significantly regulated genes in DENV- and HIA
DENV-infected Aag2 cells. Functional group abbreviations: CS,
cytoskeletal and structural; CSR, chemosensory reception; DIV,
diverse functions; DIG, blood and sugar food digestive; IMM,
immunity; MET, metabolism; PROT, proteolysis; RSM, redox,
stress and mitochondrion; RTT, replication, transcription, and
translation; TRP, transport; UNK, unknown functions.
Found at: doi:10.1371/journal.pone.0010678.s002 (0.86 MB
DOC)
Table S3 Averaged data from three biological replicate semi-
quantitative PCR assays. Averaged data from three biological
replicate semi-quantitative PCR assays of cecropin and defensin
expression at varying time points post-secondary bacterial
challenge of DENV- or mock-infected Aag2 cells. The fold change
in gene expression compared to the 0 h time point is shown. p-
values are for a Student’s t-test comparing fold change in gene
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mock-infected cells. *, p,0.05; SEM, standard error of the mean;
ND, non-detectable.
Found at: doi:10.1371/journal.pone.0010678.s003 (0.05 MB
DOC)
Table S4 Average of four biological replicate OD595 readings.
Average of four biological replicate OD595 readings for (A) E. coli,
(B) S. aureus, and (C) M. luteus after a 12-h incubation at 28uC with
DENV- or mock-infected Aag2 cells. p-values are for a Student’s t-
test comparing OD595 of bacteria incubated with DENV- and
mock-infected cells. *, p,0.05; SEM, standard error of the mean.
Found at: doi:10.1371/journal.pone.0010678.s004 (0.06 MB
DOC)
Table S5 Averaged data from three biological replicate plaque
assays of DENV titers. Averaged data from three biological
replicate plaque assays of DENV titers in cell culture supernatants
following pre-immune stimulation with E. coli, S. aureus, or PBS. p-
values are for a Student’s t-test comparing DENV titers in
bacteria-stimulated cells with PBS-treated cells. *, p,0.05; SEM,
standard error of the mean.
Found at: doi:10.1371/journal.pone.0010678.s005 (0.04 MB
DOC)
Table S6 Cluster analysis. Cluster analysis of 238 genes that
were regulated in at least two of three treatments: DENV infection
in the cell line, HIA DENV infection in the cell line, Cactus
silencing in A. aegypti mosquitoes (Figure 1D).
Found at: doi:10.1371/journal.pone.0010678.s006 (0.36 MB
DOC)
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